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Summary. — Amyotrophic lateral sclerosis (ALS) is a neurodegenerative disease
with unknown etiology characterized by progressive loss of the motor neurons in
the cerebral motor cortex, brainstem and anterior horns of the spinal cord which
determines the gradual loss of voluntary muscle function. Due to inadequate in-
vestigation tools, it is not easy to reach a qualitative and quantitative analysis of
anatomical variations induced by the disease. In fact, conventional 2D imaging (his-
tology or electron microscopy) produces an incomplete spatial coverage that leads
to possible errors in data interpretation, while standard 3D tomographic imaging
reaches insufficient resolution and contrast. High resolution X-ray Phase Contrast
Tomography (XPCT) allows the simultaneous and three-dimensional visualization
of the vascular and neuronal networks of the spinal cord on scales of length rang-
ing from millimeters to hundreds of nanometers, without the use of contrast agent,
sectioning or destructive sample preparation.
1. – Introduction
ALS incidence is 2 cases per 100000 persons every two years and the average life
expectancy varies between 3 and 5 years after diagnosis.
Disease progression especially affects motor neurons in the spinal cord, responsible
for transferring signals that control muscles contraction through the body [1]. ALS cases
are often divided into two different forms: sporadic cases represent approximately 90%
of the total (sALS), while in the remaining 10% a clear family history is present (fALS).
This study will focus on the effects of familial ALS progression, using the G93A-SOD1
animal model [2] at different time points starting from a pre-symptomatic stage of the
disease. This animal model mimics ALS inducing mutations in the superoxide dismutase
gene 1 (SOD1), located on chromosome 21q22.
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We exploit XPCT 3D images to investigate the alterations in vascular and neuronal
networks in the lumbar region of the spinal cord. To characterize neuronal and vascular
alterations, the entire spinal cord of 3 mice for each time point (Pre-symptomatic, 60 days
old, 90 days old) has been analyzed and compared with control samples.
The analysis was extended to the peripheral nervous system, since recent works [3]
exploit the correlation between the presence of denervation in peripheral nerves and
neuron depletion in the spinal cord. In this sense, sciatic nerves were extracted from the
same samples used for spinal cord analysis. A comparison between a 60 days old mouse
and the control is shown.
2. – In-line phase contrast imaging and experimental setup
Phase contrast imaging is based on phase variations induced on the incident coherent
X-ray beam by the sample. Since in-line free space propagation imaging (XPI) [4] is based
on Fresnel’s diffraction patterns after free space propagation, measuring the variations
of the real part of the refractive index, a coherent light source like synchrotron radiation
is needed. This technique allows the visualization of low absorbing materials thanks to
its great contrast sensitivity when imaging details with similar densities [5].
The tomographic images were recorded at a single sample-detector distance and the
phase retrieval algorithm proposed by Paganin [6] was applied to all the projections.
All the samples were measured at the ID17 beamline at ESRF in Grenoble, France.
The experiment on ALS-affected mice spinal cord was performed with a monochromatic
incident X-ray beam using an energy of 30 keV. The sample was set at 2.3 m from the
CCD camera with a pixel size of 3.5 μm. The tomography has been acquired with 2000
projections covering a total angle range of 360◦ with acquisition time of 1 second per
point. In this experiment we acquired the entire spinal cord.
The experiment on ALS-affected mice sciatic nerves was performed with a polychro-
matic, “pink”, incident X-ray beam using an energy of 44 keV. The sample was set
at 1.2 m from the CCD camera having a pixel size of 0.7 μm. Data pre-processing,
phase retrieval and reconstruction were performed with the SYRMEP Tomo Project
software [7, 8].
3. – Results
XPCT allowed a 3D reconstruction of the entire spinal cord at each time point (fig. 1).
The analysis was concentrated on the lumbar region of the spinal cord to simultaneously
visualize neuronal cells and the vascular network. For the neuronal network a gray-level
based quantification of motor neuron cells was possible because motor neurons appear as
bright object in the tomographic volume. We analysed the same portion of the anterior
horn at different time points of the disease and we plotted the percentage of motor
neuron depletion with respect to the control sample. We correlated these results with
the detection of vasculature in the same mice, plotting the number of branches per mm3,
normalized with the control sample. We found a significant loss of detectability of motor
neurons as the time point of the disease increases and a slight decrease of the number of
branches in the vascular network at the same time points.
Sciatic nerves, belonging to the same mice used for the spinal cord analysis, where im-
aged at higher resolution to visualize nerve fibers structure. Fibers orientation was quan-
tified from 0◦ to 180◦ in the 60 days old sample with respect to the control. The 60 days
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Fig. 1. – (a) 3D rendering of the lumbar region of a 60 days old mouse spinal cord, the motor neu-
rons are rendered in yellow while the vascular network is rendered in orange. The detectability of
motor neuron decreases while the disease progresses. In the vascular network a slight decrease is
present in the number of branches from a pre-symptomatic to a 90 days old stage of the disease.
The images were acquired with an isotropic pixel size of 3.5 μm at the ID17 beamline ESRF,
Grenoble (France).
mouse presents a sparser distribution of fibers in the sciatic nerve with respect to the
flat distribution of the control.
4. – Conclusions
Research on neurodegenerative diseases necessitates in-depth investigation from the
whole organ to the single cell. Enabling the quantifying simultaneous visualization of
micrometric structures inside tissue, XPCT is capable of quantifying the neuro-vascular
damage at different stages of the disease. Mainly, it was possible to monitor the disease
evolution even from an early pre-symptomatic stage. We demonstrated that XPCT
enables a 3D reconstruction of the whole spinal cord without sample sectioning, without
the use of any contrast agent or aggressive chemical preparation.
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